Dr. Joe Duarte: Bullish on “Coronavirus stocks”: Gilead (NASDAQ: GILD) & Emergent Biosolutions (NYSE: EBS)

Dr. Joe Duarte, M.D.

Exclusive interview with Dr. Joe Duarte, MD. publisher of “In The Money Options”  sharing some of his trading strategies, and current stocks picks. He is the author of “Successful biotech investing” (one of his published books) and biotech stocks have a special place in his heart.  A few of the biotech stocks he is currently focused on include Gilead (NASDAQ: GILD) and Emergent Biosolutions Inc. (NYSE: EBS) which are attracting investor attention because of their relation to the Coronavirus.

Gilead entered the spotlight recently with it’s antiviral Remdesivir which is in clinical trials in China, as a possible treatment for the coronavirus. Dr. Joe Duarte is bullish on GILD and believes the stock is now  waking up after 5 year slump. Dr. Duarte also is a bullish on Emergent Biosolutions Inc. (NYSE: EBS) which has a strong position in the vaccines space and reported strong earnings last week. From a technical perspective, EBS stock is breaking out to the upside.

Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.